ID: ALA2313336

Max Phase: Preclinical

Molecular Formula: C35H42N4O12

Molecular Weight: 710.74

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  [N-]=[N+]=NCCCO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](OCc3ccc(Oc4ccccc4)cc3)[C@H]2O)[C@H](O)[C@H]1NC(=O)c1ccccc1

Standard InChI:  InChI=1S/C35H42N4O12/c36-39-37-16-7-17-46-34-27(38-33(45)22-8-3-1-4-9-22)29(43)31(26(19-41)50-34)51-35-30(44)32(28(42)25(18-40)49-35)47-20-21-12-14-24(15-13-21)48-23-10-5-2-6-11-23/h1-6,8-15,25-32,34-35,40-44H,7,16-20H2,(H,38,45)/t25-,26-,27-,28+,29-,30-,31-,32+,34-,35+/m1/s1

Standard InChI Key:  DMKMBVXEHQBTGT-OKBDKMGCSA-N

Associated Targets(Human)

Galectin-3 545 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Galectin-1 387 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 710.74Molecular Weight (Monoisotopic): 710.2799AlogP: 1.78#Rotatable Bonds: 16
Polar Surface Area: 234.39Molecular Species: ACIDHBA: 13HBD: 6
#RO5 Violations: 3HBA (Lipinski): 16HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: -10.20CX Basic pKa: CX LogP: 1.56CX LogD: 1.45
Aromatic Rings: 3Heavy Atoms: 51QED Weighted: 0.05Np Likeness Score: 0.65

References

1. van Hattum H, Branderhorst HM, Moret EE, Nilsson UJ, Leffler H, Pieters RJ..  (2013)  Tuning the preference of thiodigalactoside- and lactosamine-based ligands to galectin-3 over galectin-1.,  56  (3): [PMID:23281927] [10.1021/jm301677r]

Source